Home/Filings/4/0001140361-25-005844
4//SEC Filing

Shah Gaurav 4

Accession 0001140361-25-005844

CIK 0001281895other

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 4:01 PM ET

Size

6.2 KB

Accession

0001140361-25-005844

Insider Transaction Report

Form 4
Period: 2025-02-21
Shah Gaurav
DirectorCEO
Transactions
  • Sale

    Common Stock

    2025-02-21$10.58/sh16,303$172,486772,680 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    207,897
  • Common Stock

    (indirect: By Trust)
    198,341
Footnotes (2)
  • [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
  • [F2]The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.

Issuer

ROCKET PHARMACEUTICALS, INC.

CIK 0001281895

Entity typeother

Related Parties

1
  • filerCIK 0001725922

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 4:01 PM ET
Size
6.2 KB